Given the strong association between PCI for CTO and perforation, a greater understanding of perforation during PCI for CTO is, therefore, warranted and is of particular Background-Coronary perforation (CP) during chronic total occlusion percutaneous coronary intervention for stable angina (CTO-PCI) is a rare but serious event. The evidence base is limited, and the long-term effects are unclear. Using a national PCI database, the incidence, predictors, and outcomes of CP during CTO-PCI were defined. Methods and Results-Data analyzed from the British Cardiovascular Intervention Society data set on all CTO-PCI procedures performed in England and Wales between 2006 and 2013. Multivariate logistic regressions and propensity scores were used to identify predictors of CP and its association with outcomes. A total of 376 CP were recorded from 26 807 CTO-PCI interventions (incidence of 1.40%) with an increase in frequency during the study period (P=0.012). Patient-related factors associated with an increased risk of CP were age and female sex. Procedural factors indicative of complex CTO intervention strongly related to an increased risk of CP with a close relationship between the number of complex strategies used and CP evident (P=0.008 for trend). Tamponade occurred in 16.6% and emergency surgery in 3.4% of cases. Adverse outcomes were frequent in those patients with perforation including bleeding, transfusion, myocardial infarction, and death. A legacy effect of perforation on mortality was evident, with an odds ratio for 12-month mortality of 1.60 for perforation survivors compared with matched nonperforation survivors without a CP (P<0.0001). Conclusions-Many of the factors associated with an increased risk of CP were related to CTO complexity. Perforation was associated with adverse outcomes, with a legacy effect on later mortality after CP also observed. 
C oronary perforation (CP) is a rare but serious complication of percutaneous coronary intervention (PCI) with a previously estimated incidence of ≈0.4%. 1 Although there are several published series of CP, the rarity of the complication has previously been limited to small numbers of cases derived from single-center experience. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Most recently, we have published a national analysis of temporal trends, predictors, and outcomes of CPs in the United Kingdom and observed that among the strongest independent predictors of CP was PCI undertaken for total occlusion intervention (CTO) lesions (odds ratio, 3.96; 95% confidence interval, 3.28-4.7).
importance and interest given the utilization of newer techniques such as subintimal tracking, reentry devices, and retrograde approach and potential for these strategies to lead to coronary complications without careful training. The most informative study to date is a meta-analysis of CTO studies, reporting 418 perforations from 12 254 procedures with a pooled estimated incidence of 2.9%. 18 However, no data were presented on the predictors of CP during CTO intervention, its association with outcomes, and the temporal trends in its incidence or outcome. Therefore, the objectives of the present study were, for the first time, to define the true incidence and temporal trends of CP during CTO-PCI through analysis of a national database. Additionally, we aimed to describe which factors are independently predictive of CP and to define the short-and long-term outcomes after CP.
Methods Study Design, Setting, and Participants
We analyzed national data from all patients with stable angina who underwent PCI for chronic CTO in England and Wales between January 2006 and December 2013.
Setting, Data Source, and Study Size
Data on PCI practice in the United Kingdom were obtained from the British Cardiovascular Intervention Society (BCIS) data set that records this information prospectively and publishes this information in the public domain as part of the national transparency agenda. 19 The data collection process is overseen by The National Institute of Cardiovascular Outcomes Research (http://www.ucl.ac.uk/nicor/) with high levels of case ascertainment. In 2013, 98.6% of all PCI procedures performed in the National Health Service hospitals in England and Wales (www.bcis.org.uk/) were recorded on the database. The BCIS-National Institute of Cardiovascular Outcomes Research database contains 113 clinical, procedural, and outcomes variables with ≈80 000 new records added each year. The participants of the database are tracked by the Medical Research Information Services for subsequent mortality using the patients' National Health Service number (a unique identifier for any person registered within the National Health Service in England and Wales).
Study Definitions
We analyzed all recorded CTO-PCI procedures that were undertaken for stable angina in England and Wales between January 1, 2006, and December 31, 2013. Patients were categorized according to whether they sustained a CP during CTO-PCI or not. The outcomes examined were in-hospital mortality, 30-day mortality, 1-year mortality, 5-year mortality, in-hospital reinfarction, in-hospital emergency coronary artery bypass graft (CABG), in-hospital cardiac tamponade, in-hospital stroke, and in-hospital major bleeding (defined as gastrointestinal bleed, intracerebral bleed, retroperitoneal hematoma, blood or platelet transfusion, or an arterial access site complication requiring surgery). Complex CTO procedures were defined as those involving any one of the following: dual arterial access, rotational/laser atherectomy, penetration catheter (including Tornus and Gopher), microcatheter or Crossboss/Stingray balloon, and intravascular ultrasound. To estimate the severity of coronary disease, a diseased vessel was defined as a stenosis >75% and the total calculated as the sum of diseased vessels. Baseline and residual disease defined as the total number of vessels with this degree of disease at the start and end of the PCI procedure.
Data Analyses
To calculate the overall incidence of CP, the total number of perforations was divided by the total number of PCI cases between 2006 and 2013. Participants with missing information on CP and CTO status were excluded. In addition, the rates of CP for each year of study were calculated and analyzed using linear regression. We examined the baseline and procedural characteristics of participants by CP status. These variables included age, sex, smoking status, body mass index, family history of coronary heart disease, hypertension, hyperlipidemia, diabetes mellitus, previous myocardial infarction, previous stroke, peripheral vascular disease, valvular heart disease, renal disease, previous PCI, previous CABG, left ventricular function, antiplatelet therapy, warfarin use, bivalirudin use, glycoprotein IIb/IIIa inhibitors use, vessel attempted for PCI (graft, left main, left anterior descending, circumflex, right coronary), radial access, and stent implanted, rotational atherectomy use, laser angioplasty use, cutting balloon use, presence of a chronic occlusion, surgical cover, and year of PCI. We tested for associations between each categorical variable and CP using a χ 2 test, and for continuous variables, we used 1-way ANOVA. We then performed a multivariate analysis of the predictors of perforation using multivariate logistic regression to investigate the influence of variables that have the potential for being included in the linear component of a logistic regression model. Final model selection was done as follows: we first imputed missing data on baseline covariate using multiple imputations with chained equation given that ≈20% of the observations had missing data (missing data points are presented in Table I in the Data Supplement). We then ran a stepwise forward selection with a proportional hazard model with P<0.1 as entry criteria. To examine the associates of perforation and test whether those associates show a trend over time (from 2006 to 2013), a Cochran-Armitage test for trend was used for associates reported as categorical variables and a linear regression for the continuous variables.
The outcomes of interest were 30-day mortality, 1-year mortality, 5-year mortality, in-hospital bleeding, reinfarction, emergency CABG, stroke, cardiac tamponade, side-branch occlusion, and coronary dissection for which we initially calculated the crude rates by CP status. Individual logistic regressions were done on the imputed data
WHAT IS KNOWN
• It is known that coronary perforation is a rare but devastating complication of percutaneous coronary intervention (PCI) with certain groups at greater risk of perforation.
• Contemporary techniques in chronic total occlusion (CTO)-PCI such as dissection/reentry, retrograde recanalization, and specialised reentry devices might increase the risk of perforation with specialised CTO registries reporting higher rates than in non-CTO cohorts.
WHAT THE STUDY ADDS
• We report a large cohort of CTO-PCI with almost 400 perforations and as such it is the largest CTO cohort thus far reported. The overall incidence was 1.2%, which is higher than non-CTO-PCI and increased during the study period.
• With a large number of events, we were able to identify the main predictors of perforation during CTO-PCI, and these included age, female sex, and PCI complexity.
• We identified not only a significant impact on early morbidity and mortality of a perforation, but also a longer-term legacy effect on 12-month mortality.
set for each of the MACE events according the perforation status of the patients to quantify the independent association between perforation and outcomes.
Finally, from the subset of patients who survived ≤30 days, we explored the association between perforation at procedure, and mortality at 12 months a time-to-event analysis was performed using Kaplan-Meier curves, log-rank tests, and Cox proportional hazard model to estimate the corresponding hazard ratio. To adjust for baseline imbalances, we performed a propensity score analysis to balance for important covariates that might bias estimates for causal inferences. The following variables that were associated with 12-month mortality in the 30-day survivors were used in the propensity score analysis: sex, age at procedure, New York Heart Association status, body mass index, previous myocardial infarction, previous CABG, diabetes mellitus, baseline disease severity, hypertension, smoking status, renal insufficiency, and Q wave on ECG. The propensity score method used in this article is the inverse probability of treatment weighting. Inverse probability of treatment weighting uses weights based on the propensity score to create a synthetic sample in which the distribution of measured baseline variables is independent of treatment allocation. More precisely, one estimates the probability that a particular patient is assigned to 1 of the 2 groups as a function of that individual's covariates (the propensity score). Using a logistic regression, propensity scores were calculated based on the 11 covariates specified above. The estimated propensity score is then the predicted probability of treatment derived from the fitted regression model. Each individual observation was then given a weight equal to the inverse of this propensity score to create 2 pseudo-populations of exposed and unexposed patients who now represent what would have happened to the entire population under those 2 treatment conditions. The advantage of this method is that it is inclusive as it uses all patients in a study; therefore, no loss of sample occurs as in other conditioning methods such as matching or stratification. We also normalized the weights by dividing them by the mean weight. Those weights were then used to derive weighted Kaplan-Meier curves and weight hazard ratios.
Results

Incidence and Baseline Demographics by Perforation Status
Between 2006 and 2013, 376 CPs were recorded from 26 807 stable angina CTO interventions giving an overall incidence of 1.40%. Total PCI and CTO-PCI numbers are presented in Figure 1 and show a decline in the contribution of CTO-PCI as percentage of total PCI volume although the crude numbers of CTO-PCI remained relatively stable. Annual incidence of perforation during CTO intervention plotted over time (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) is illustrated in Figure 2A showing a significant temporal increase (R 2 =0.65; P=0.015). The baseline demographics for patients with and without CP are presented in Table 1 . Patients with CP were more often female or older but in general did not have a greater burden of comorbidity such as hypertension, cerebrovascular disease, or renal dysfunction. CP was more likely to occur in patients with a previous history of PCI. 
Procedural Variables by Perforation Status
The procedural variables for patients with and without CP are presented in Table 2 . In contrast to patient baseline characteristics, there were many significant differences among procedural variables in patients who sustained a CP compared with those who did not. Additionally, the complexity of the intervention was closely associated with CP with a primary consultant operator, dual arterial access, rotational atherectomy, microcatheter use, and Crossboss/Stingray use, all more frequently observed when perforation occurred. Figure 2B illustrates the percentage of cases using any complex CTO kit over time with more than half of the cases in 2013 using at least 1 contemporary CTO technique. Figure 3 illustrates an increase in the complexity of both the patients and procedures during the study period. A close relationship between the number of complex strategies used and CP frequency was evident and is illustrated in Figure 4 (P=0.008 for trend).
Predictors of CP During CTO-PCI
Using multivariate analyses, covariates found to be associated with CP were identified and are presented in Table 3 . The only patient-related factors associated with an increased risk of perforation were age, female sex, and a history of a previous PCI. Procedural factors associated with an increased risk of perforation were Crossboss/Stingray use, rotational or laser atherectomy, and microcatheter use. Circumflex intervention and a junior primary operator were predictive of a lower risk of CP.
Clinical Outcomes by Perforation Status
All procedural complications and adverse outcomes recorded in the BCIS database were more frequent in patients with CP ( greater in those patients with CP. Temporal changes in mortality are displayed in Figure I in the Data Supplement and were nonsignificant (P=0.96). Using individual logistic regressions, the odd ratios of clinical outcomes associated with CP are presented in Table 5 . An excess of 12-month mortality in 30-day survivors for patients with and without perforation was associated with increased age and baseline comorbidity (Table II in the Data Supplement). Figure 5A illustrates the unadjusted KaplanMeier plots for mortality by perforation status to 12 months, confirming the significant impact of a perforation on patient survival. Figure 5B illustrates propensity score-adjusted Kaplan-Meier plots for mortality by perforation status for perforation survivors from 30 days to 12 months compared with nonperforation survivors from 30 days to 12 months. Using propensity scores analyses for each patient derived from the inverse probability of treatment weight method, a legacy effect (ie, a continued impact of perforation on mortality) was evident with a hazards ratio for 12-month mortality of 1.60 compared with those patients without a CP (P<0.0001).
Discussion
The current study is the first analysis of CP as a complication of PCI for chronic total occlusive disease performed from a national angioplasty database. Although there are several previously published series, their small size has limited the robustness of any conclusions, and in particular, temporal trends and independent predictors of CP have not previously been defined because of the small patient numbers previously studied.
The current study characterizes the rate of CP during CTO-PCI as 1.4%, which is 4 times greater than for patients not being treated for CTOs from the same national database. 17 This presumably reflects the complexity of interventional procedures associated with chronic occlusive disease. However, the observed incidence was lower than that in previous series of CTO intervention with a meta-analysis of 64 published series recording a rate of 2.9%. Additionally, in specialized CTO registries such as PROGRESS and OPEN-CTO registry, higher rates are also recorded. [18] [19] [20] These differences in reported frequency may reflect publication bias but also likely center bias with CP being observed more frequently in specialist CTO centers with more complex cases. Indeed, in the current study, it was clearly evident that-in contrast to a more general PCI population-it was not patient-related factors (apart from age and sex) that were most predictive of perforation but rather procedural and anatomic factors. The most important predictors were those usually associated with more complex occlusive disease, a history of PCI (and within this there will be some patients with a previous failed CTO attempt), and complexity of the interventional devices (as evidenced by use of rotational/ laser atherectomy, microcatheters, and Crossboss/Stingray), all more frequently observed with CP.
The study findings seem to support an increased incidence of CP as case complexity increases. First, there was an association between the number of study-defined complexity indicators (such as dual access, Corsair, intravascular ultrasound, and rotational atherectomy use) and perforation occurrence. Second, there was a temporal relationship between complex kit utilization and perforation incidence. Finally, further evidence of CTO complexity relating to perforation was supported by a lower likelihood of a trainee interventionalist being the first operator when a CP occurred, that is, the more complex a perforation, the more likely a senior interventionalist was first operator and the more likely a perforation would occur. These observations seem plausible given the development of techniques such as dissection/reentry and the retrograde approach and highlight the need for optimal training in novel CTO strategies, preprocedural planning, familiarization with the characteristics all components of the CTO tool box, and a clear plan of action should such a complication occur. 21, 22 It is testament to skill of the operators that despite the significant increase in the complexity of the patients undergoing CTO-PCI (as evidenced for example by an increase in age, renal disease, peripheral vascular disease, and left main intervention in patients undergoing CTO-PCI), there was a low rate of mortality associated with perforation. Furthermore, there was also a low rate of emergency surgery despite a high rate of tamponade. The avoidance of surgical repair is clearly highly desirable, and the utilization of covered stents, as well as a wider appreciation of techniques such as ping-pong guides, and embolization coils, distal fat, or thrombus embolization to treat wire tip perforations have facilitated such low rates. 23, 24 However, despite this, the incidence of major adverse events in patients with CP was high with a 5-fold increase in 30-day mortality. These data are a stark reminder that although CP during PCI is a relatively rare event, when it does occur, there is an important association with poor outcome. For the first time, the article identifies a legacy effect of CP during CTO procedures, that is, a continued excess mortality after 30 days even when cases were propensity scored to match with patients who did not experience a perforation. There are several plausible hypotheses that might explain this observation. The number of successful lesions was significantly less in cases complicated by perforation, with thrombolysis in myocardial infarction 0 final flow almost twice as likely to be present. Additionally, there was a significant difference in residual disease burden in the 2 groups, which was highly statistically significant. Although there is a small difference in baseline disease severity (delta 0.09 vessels), the residual disease difference was of a much greater magnitude (delta 0.34 vessels). Therefore, the excess residual disease burden in the main seems driven by the occurrence of a perforation. The logical explanation for this observation is that once a perforation occurs, the PCI procedure is often terminated, and the focus shifts to managing the perforation. In this instance, other vessels would most likely be left untreated. A previous analysis of all CTO cases from the National Institute of Cardiovascular Outcomes Research data set adds further evidence to the mechanism of incomplete revascularization and the legacy effect. This study demonstrated that complete revascularization during CTO intervention was associated with improved survival compared with partial revascularization or failed revascularization. 25 Therefore, it seems possible that the lower rates of procedural success and greater residual disease after a CP might drive longer-term mortality. A further factor to consider is that if a patient experiences such a life-threatening complication with a prolonged hospital admission during a failed attempt to reopen a CTO, the likelihood of that patient undergoing a repeat procedure understandably would be lower than the likelihood of a repeat procedure being undertaken after a failed CTO without a perforation (driven by patient and physician choice). Other mechanistic possibilities include side-branch loss with periprocedural myocardial infarction, 26 excess access site complications, 27 major bleeding, 28, 29 and transfusion, 30 all of which were significantly more common with perforation and are associated with excess 12-month mortality. Covered stent use may also be associated with poor 12-month outcomes. Small series have reported high rates of stent thrombosis, restenosis, and mortality with their use. 24, 31 Finally, CPs may occur more commonly in patients with more extensive/severe disease and in those patients who are frailer and with more comorbidity. Although we have attempted to adjust for differences in baseline covariates/clinical characteristics using advanced statistical methodology, there remains the possibility of residual confounding which might in part contribute to the legacy effect that we report.
This analysis has several strengths. The BCIS data set includes >98% of all PCI procedures performed in the United Kingdom, which, therefore, reflects a national, real-world experience that includes high-risk patients encountered in daily interventional practice (who are often excluded from randomized controlled trials). Such large national registry data with unselected enrollment are important for evaluation of low-frequency complications such as CP, particularly given that such low event rates would mean that single-center registries or randomized controlled trials would be grossly underpowered.
Limitations
As with any database, the robustness of the conclusions are directly related to the quality of data entered. Although there are high levels of case ascertainment and field completion within the database, the accuracy of field completion for individual centers cannot be validated. The BCIS database does not differentiate between CPs resulting from guidewire and perforations because of vessel rupture by balloon or stent inflation. Therefore, we are unable to provide separate analyses regarding the predictors and outcomes of these subgroups of CP. Additionally, the definition of perforation was not standardized, and the database does not record the Ellis classification of CP. Therefore, a substratification by perforation severity was not possible within the constraints of the current data set. A further limitation is the lack of angiographic data recorded in the BCIS database to classify CTO complexity. Therefore, the relationship of CP with antegrade and retrograde techniques cannot be studied. Finally, the only emergency treatment as an outcome after CP that is recorded in the BCIS database is emergency surgery. Therefore, we are unable to provide data on the frequency of the use of other treatment strategies such covered stents, pericardial drains, or embolization techniques.
Conclusions
Using data derived from a national PCI database, CP as a complication of CTO intervention occurred in 1.4% of cases but with a significant temporal increase in frequency. Independent predictors of CP included age, female sex, CTO complexity, and consultant operator. CP was strongly associated with poor outcomes. Finally, a legacy effect on mortality after CP was observed with a continued excess mortality between 30 days and 12 months.
